After successful conjugation, the DOX-NP conjugate was coated with hyaluronic acid (HA) to allow for better targeting since HA has a high affinity to CD-44 glycoproteins that are usually overexpressed in cancer cells. The gene discussed is CD44; the disease is cancer.